(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
0.04% £ 23.99
Live Chart Being Loaded With Signals
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery...
Stats | |
---|---|
Volumen de hoy | 7.43M |
Volumen promedio | 5.82M |
Capitalización de mercado | 5.52B |
EPS | £0.0361 ( 2023-08-31 ) |
Last Dividend | £0.0443 ( 2020-03-19 ) |
Next Dividend | £0 ( N/A ) |
P/E | 2 399.00 |
ATR14 | £0.166 (0.69%) |
Volumen Correlación
Abcam plc Correlación
10 Correlaciones Más Positivas | |
---|---|
MSAC | 0.953 |
KAII | 0.95 |
MLAI | 0.95 |
QUIK | 0.947 |
CAR | 0.946 |
BTBT | 0.944 |
GGAL | 0.944 |
LGAC | 0.943 |
ALSA | 0.943 |
NVSA | 0.94 |
10 Correlaciones Más Negativas | |
---|---|
PRPO | -0.962 |
PSCH | -0.955 |
PSCC | -0.942 |
VORB | -0.942 |
VIVE | -0.938 |
PRFZ | -0.938 |
PTH | -0.937 |
PNQI | -0.935 |
ORPH | -0.935 |
SENEA | -0.932 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Abcam plc Correlación - Moneda/Commodity
Abcam plc Finanzas
Annual | 2022 |
Ingresos: | £361.70M |
Beneficio Bruto: | £270.50M (74.79 %) |
EPS: | £-0.0372 |
FY | 2022 |
Ingresos: | £361.70M |
Beneficio Bruto: | £270.50M (74.79 %) |
EPS: | £-0.0372 |
FY | 2021 |
Ingresos: | £297.70M |
Beneficio Bruto: | £211.80M (71.15 %) |
EPS: | £0.0780 |
Financial Reports:
No articles found.
Abcam plc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.0358 | 2014-03-19 |
Last Dividend | £0.0443 | 2020-03-19 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | £0.836 | -- |
Avg. Dividend % Per Year | 0.02% | -- |
Score | 3.14 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 2.72 | |
Div. Directional Score | 6.68 | -- |
Year | Amount | Yield |
---|---|---|
2014 | £0.122 | 1.59% |
2015 | £0.124 | 1.78% |
2016 | £0.117 | 1.23% |
2017 | £0.114 | 1.26% |
2018 | £0.158 | 1.12% |
2019 | £0.157 | 1.10% |
2020 | £0.0443 | 0.24% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.000600 | 1.500 | 9.99 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.000268 | 1.200 | 9.99 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.000380 | 1.500 | -1.107 | -1.660 | [0.1 - 1] |
payoutRatioTTM | 22.73 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.354 | 0.800 | 8.23 | 6.58 | [1 - 3] |
quickRatioTTM | 0.993 | 0.800 | 8.86 | 7.09 | [0.8 - 2.5] |
cashRatioTTM | 0.418 | 1.500 | 8.79 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.211 | -1.500 | 6.48 | -9.72 | [0 - 0.6] |
interestCoverageTTM | 9.21 | 1.000 | 7.70 | 7.70 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0180 | 2.00 | 9.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.302 | -1.500 | 8.79 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.779 | 1.000 | 0.352 | 0.352 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.104 | 1.000 | 9.92 | 9.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.121 | 1.000 | -0.440 | -0.440 | [0.2 - 2] |
assetTurnoverTTM | 0.446 | 0.800 | -0.360 | -0.288 | [0.5 - 2] |
Total Score | 10.65 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 16 180 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.000380 | 2.50 | -0.712 | -1.660 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0180 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.113 | 2.00 | 9.96 | 10.00 | [0 - 30] |
payoutRatioTTM | 22.73 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -68.63 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0572 | 1.000 | -1.070 | 0 | [0.1 - 0.5] |
Total Score | 2.72 |
Abcam plc
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico